Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001086364-12-002674
Filing Date
2012-07-11
Accepted
2012-07-10 17:54:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 nabi.biopharmaceuticals..txt SC 13G/A 10271
  Complete submission text file 0001086364-12-002674.txt   12286
Mailing Address 12270 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12270 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
NABI BIOPHARMACEUTICALS (Subject) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-31596 | Film No.: 12956629
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 55 EAST 52ND STREET NEW YORK NY 10055
Business Address 55 EAST 52ND STREET NEW YORK NY 10055 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

EIN.: 320174431 | State of Incorp.: DE | Fiscal Year End: 0226
Type: SC 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies